Guida, Michele
Istituto Tumori Bari
3 papers on CoChatORCID 0000-0001-8411-0319
Most cited papers
- Verified
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Hamid, O., Schmidt, H., Nissan, A., Ridolfi, L., Aamdal, S., Hansson, J., Guida, M., Hyams, D. M., Gómez, H., Bastholt, L., et al. (2011) · Journal of Translational Medicine
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 534
- Verified
Ocular Toxicity in Metastatic Melanoma Patients Treated with Mitogen-Activated Protein Kinase Kinase Inhibitors: A Case Series
Niro, A., Strippoli, S., Alessio, G., Sborgia, L., Recchimurzo, N., & Guida, M. (2015) · American Journal of Ophthalmology
Drug-Induced Ocular ToxicityOcular Oncology and Treatments
Cited by 45
- Verified
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients
Comes, M. C., Fucci, L., Mele, F., Bove, S., Cristofaro, C., De Risi, I., Fanizzi, A., Milella, M., Strippoli, S., Zito, A., et al. (2022) · Scientific Reports
AI in cancer detectionCutaneous Melanoma Detection and Management
Cited by 33
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free